- Home>
- Primary Care>
- Women's Health>
- Ovarian Cancer
Search for Ovarian Cancer in Women's Health
Physician-authored summaries on the latest research on ovarian cancer, editorials on ovarian cancer, and perspectives on ovarian cancer - drawn from the top medical journals.
You searched for: ovarian cancer Items 1 to 20 of 75 results
Sort by:
- Relevance
- Date
-
Ovarian Cancer Still Defies Early Detection
- January 24, 2008
- Sandra Ann Carson, MD
CA125 and transvaginal ultrasound were ineffective as surveillance tools for ovarian cancer.- Covering:
- Woodward ER et al., BJOG 2007 Dec; 114:1500.
-
Breast-Feeding and Ovarian Cancer Prevention: Longer Is Better
- May 31, 2007
- Andrew M. Kaunitz, MD
Breast-feeding for 18 months or longer was associated with decreased risk for ovarian cancer. CME Exam- Covering:
- Danforth KN et al., Cancer Causes Control 2007 Jun; 18:517-23.
-
Menopausal Hormone Therapy and Ovarian Cancer Risk
- May 24, 2007
- Andrew M. Kaunitz, MD
Current HT use for more than 5 years was associated with elevated risk for ovarian cancer. CME Exam- Covering:
- Beral V et al., Lancet 2007 May 19; 369:1703-10.
- Narod SA., Lancet 2007 May 19; 369:1667-8.
-
Do Ovarian Cancer Outcomes Vary by Type of Specialist Providing Chemotherapy?
- May 3, 2007
- Andrew M. Kaunitz, MD
Gynecologic and medical oncologists employed different approaches to chemotherapy, but ovarian cancer survival was nearly identical.- Covering:
- Silber JH et al., J Clin Oncol 2007 Apr 1; 25:1169-75.
-
BRCA Test Negative? Your Patient Is Still High Risk
- January 4, 2007
- Andrew M. Kaunitz, MD
Women from high-risk families who test negative for BRCA mutations are at elevated risk for breast and ovarian cancer.- Covering:
- Smith A et al., J Med Genet 2006 Nov 1;:[Epub ahead of print].
-
Early Symptoms of Ovarian Cancer
- October 18, 2005
- Andrew M. Kaunitz, MD
Abdominal pain and swelling, pelvic pain, and GI symptoms appear to be much more common in women with ovarian cancer than in others, with onset many months before diagnosis.- Covering:
- Smith LH et al., Cancer 2005 Oct 1; 104:1398-407.
-
Androgenic and Nonandrogenic OCs Protect Against Ovarian Cancer
- June 7, 2005
- Sandra Ann Carson, MD
Oral contraceptives (OCs) have long been known to protect against ovarian cancer. These researchers sought to determine whether OCs containing progestins with higher androgenic properties . . .- Covering:
- Greer JB et al., Obstet Gynecol 2005 Apr; 105:731-40.
-
Ultrasound of Little Value in Identifying Early-Stage Ovarian Cancer
- June 7, 2005
- Robert W. Rebar, MD
Ovarian cancer claims more lives in the U.S. each year than all other gynecologic malignancies combined, mainly because we lack effective methods for early detection. . . .- Covering:
- Fishman DA et al., Am J Obstet Gynecol 2005 Apr; 192:1214-22.
-
Ovarian Cancer Is Not So Silent
- August 24, 2004
- Jane E. Corboy, MD
The rarity of ovarian cancer is overshadowed by its devastatingly low cure rates and the lack of effective means of early diagnosis. Media coverage of . . .- Covering:
- Goff BA et al., JAMA 2004 Jun 9; 291:2705-12.
-
Fertility Drugs and Ovarian Cancer: No Apparent Link
- August 4, 2004
- Sandra Ann Carson, MD
Previous studies have suggested associations between use of fertility drugs and ovarian cancer risk. However, infertile women, regardless of fertility drug use, are known to . . .- Covering:
- Brinton LA et al., Obstet Gynecol 2004 Jun; 103:1194-203.
-
Does Hormone Therapy Affect Ovarian Cancer Risk?
- August 7, 2002
- Christine D. Berg, MD
Risk/benefit analyses of hormone therapy (HT) have focused primarily on breast cancer and heart disease. However, ovarian cancer is another reasonable concern, given the presence . . .- Covering:
- Lacey JV Jr et al., JAMA 2002 Jul 17; 288:334-41.
-
OCs Reduce the Risk for Ovarian Cancer in Women with a Family History
- April 22, 2002
- Ann J. Davis, MD
This study shows that long-term oral contraceptive use can reduce the risk for ovarian cancer in women with a first-degree family history of this disease.- Covering:
- Walker GR et al., Am J Obstet Gynecol 2002 Jan; 186:8-14.
-
Novel Potential Screening Test for Ovarian Cancer
- April 9, 2002
- Christine D. Berg, MD
Ovarian cancer remains deadly because more than 80% of patients present with advanced disease. The most widely used biomarker for ovarian cancer is cancer antigen . . .- Covering:
- Petricoin EF et al., Lancet 2002 Feb 16; 359:572-7.
-
Infertility Drugs and Ovarian Cancer: No Evidence of Association
- March 5, 2002
- Robert W. Rebar, MD
A relation between drugs used to induce ovulation and ovarian cancer was first suggested about 10 years ago. To address this concern, investigators pooled data . . .- Covering:
- Ness RB et al., Am J Epidemiol 2002 Feb 1; 155:217-24.
-
Does OC Use Reduce Ovarian Cancer Risk in Women with BRCA Mutations?
- October 3, 2001
- AM Kaunitz
Low parity and infertility are established risk factors for nonfamilial ovarian cancer; multiparity and oral contraceptive (OC) use can reduce the risk for this uncommon . . .- Covering:
- Modan B et al., N Engl J Med 2001 Jul 26; 345:
235 240 .
- Modan B et al., N Engl J Med 2001 Jul 26; 345:
-
Does Menopausal Estrogen Therapy Increase Risk for Dying from Ovarian Cancer?
- April 17, 2001
- AM Kaunitz and MA Shepard
Studies have suggested that estrogen therapy (ET) is associated with an increased risk for ovarian cancer mortality. To examine whether duration and recency of ET . . .- Covering:
- Rodriguez C et al., JAMA 2001 Mar 12; 285:
1460 1465 .
- Rodriguez C et al., JAMA 2001 Mar 12; 285:
-
Ovarian Cancer Screening
- June 1, 1999
- MA Shepard
Ovarian cancer has a poor prognosis because early detection is difficult. These British authors assessed the efficacy of CA 125 and ultrasonography in diagnosing it . . .- Covering:
- Jacobs et al., Lancet 1999 Apr 10; 353:
1207 1210 .
- Jacobs et al., Lancet 1999 Apr 10; 353:
-
Fertility Drugs and Borderline Ovarian Cancer
- January 1, 1999
- SA Carson
Recent unconfirmed studies have suggested an association between fertility drug use and ovarian cancer. However, there are no data on the risk of borderline ovarian . . .- Covering:
- Mosgaard BJ et al., Fertil Steril 1998 Dec; 70:
1049 1055 .
- Mosgaard BJ et al., Fertil Steril 1998 Dec; 70:
-
Tumor Markers for Ovarian Cancer: The Search Goes On
- October 1, 1998
- SD Gharib
The long-term survival in late-stage ovarian cancer, during which two-thirds of cases are detected, is only 15%. Stage I disease carries a greater than 90% . . .- Covering:
- Xu Y et al., JAMA 1998 Aug 26; 280:
719 723 .
- Xu Y et al., JAMA 1998 Aug 26; 280:
-
OCs and Ovarian Cancer Risk with BRCA Mutations
- September 1, 1998
- W Levinson
Only 10% of ovarian cancer is hereditary, but many studies have examined women in this subgroup. Unselected long-term OC users have a 50% reduced ovarian . . .- Covering:
- Narod SA et al., N Engl J Med 1998 Aug 13; 339:
424 428 . - Rubin SC., N Engl J Med 1998 Aug 13; 339:
469 471 .
- Narod SA et al., N Engl J Med 1998 Aug 13; 339:
You searched for: ovarian cancer Items 1 to 20 of 75 results